{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:08:44Z","timestamp":1790629724805,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.semcancer.2022.11.006","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T12:14:33Z","timestamp":1667996073000},"page":"160-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["The role of stem cells in small-cell lung cancer: Evidence from chemoresistance to immunotherapy"],"prefix":"10.1016","volume":"87","author":[{"given":"Wenwen","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyun","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semcancer.2022.11.006_bib1","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA: a Cancer J. Clin."},{"issue":"14","key":"10.1016\/j.semcancer.2022.11.006_bib2","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2011.40.4905","article-title":"Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data","volume":"30","author":"Rossi","year":"2012","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.006_bib3","first-page":"2148","article-title":"Mechanistic exploration of cancer stem cell marker voltage-dependent calcium channel \u03b12\u03b41 subunit-mediated chemotherapy resistance in small-cell lung cancer","volume":"24","author":"Yu","year":"2018","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. Cancer Res."},{"key":"10.1016\/j.semcancer.2022.11.006_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2022.02.021","article-title":"Evolving role of immunotherapy in small cell lung cancer","author":"Barrows","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.006_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/14712598.2019.1592155","article-title":"Immunotherapy for small cell lung cancer: mechanisms of resistance","volume":"19","author":"Hamilton","year":"2019","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.semcancer.2022.11.006_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2022.03.009","article-title":"Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: perspectives for immunotherapy of SCLC","author":"Niu","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.006_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092158","article-title":"Clinical relevance of mesenchymal- and stem-associated phenotypes in circulating tumor cells isolated from lung cancer patients","volume":"13","author":"Pantazaka","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2022.11.006_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/cac2.12351","article-title":"A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability","author":"Wang","year":"2022","journal-title":"Cancer Commun. (Lond., Engl. )"},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.006_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00262-021-02998-1","article-title":"Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes","volume":"71","author":"Kursunel","year":"2022","journal-title":"Cancer Immunol., Immunother.: CII"},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.006_bib10","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1158\/0008-5472.CAN-13-1541","article-title":"CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist","volume":"74","author":"Sarvi","year":"2014","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.semcancer.2022.11.006_bib11","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.bjc.6605668","article-title":"Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer","volume":"102","author":"Salcido","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.006_bib12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1515\/raon-2015-0027","article-title":"The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer","volume":"50","author":"Sodja","year":"2016","journal-title":"Radiol. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.006_bib13","first-page":"172","article-title":"The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung","volume":"2","author":"Karachaliou","year":"2013","journal-title":"Transl. Lung Cancer Res."},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.006_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081879","article-title":"Quo VadisCancer stem cells,? The notch signaling pathway in tumor initiation and progression","volume":"9","author":"Meisel","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.006_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1172\/JCI41004","article-title":"The therapeutic promise of the cancer stem cell concept","volume":"120","author":"Frank","year":"2010","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.semcancer.2022.11.006_bib16","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/s41375-019-0460-6","article-title":"Identification of a leukemia-initiating stem cell in human mast cell leukemia","volume":"33","author":"Eisenwort","year":"2019","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.006_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ijc.29382","article-title":"Cell-surface Vimentin: a mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers","volume":"137","author":"Mitra","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"24","key":"10.1016\/j.semcancer.2022.11.006_bib18","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1007\/s00018-011-0772-9","article-title":"Lessons from common markers of tumor-initiating cells in solid cancers","volume":"68","author":"Gires","year":"2011","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"issue":"11","key":"10.1016\/j.semcancer.2022.11.006_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11111225","article-title":"Cancer stem cell-like circulating tumor cells are prognostic in non-small cell lung cancer","volume":"11","author":"Obermayr","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.semcancer.2022.11.006_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.leukres.2019.04.004","article-title":"Relationship between CD34\/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia","volume":"81","author":"Moshaver","year":"2019","journal-title":"Leuk. Res."},{"key":"10.1016\/j.semcancer.2022.11.006_bib21","article-title":"Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity","author":"Zhang","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2022.11.006_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.lungcan.2021.02.002","article-title":"A unique small cell lung carcinoma disease progression model shows progressive accumulation of cancer stem cell properties and CD44 as a potential diagnostic marker","volume":"154","author":"Heng","year":"2021","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.006_bib23","article-title":"Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.006_bib24","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","article-title":"Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo","volume":"183","author":"Goodell","year":"1996","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.006_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2005-02-0655","article-title":"Hematopoietic stem cells do not engraft with absolute efficiencies","volume":"107","author":"Camargo","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.006_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/cas.12045","article-title":"Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy","volume":"104","author":"Kubo","year":"2013","journal-title":"Cancer Sci."},{"issue":"19","key":"10.1016\/j.semcancer.2022.11.006_bib27","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","article-title":"Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells","volume":"66","author":"Clarke","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.006_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.canlet.2010.08.013","article-title":"Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells","volume":"299","author":"Zhong","year":"2010","journal-title":"Cancer Lett."},{"issue":"7355","key":"10.1016\/j.semcancer.2022.11.006_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.semcancer.2022.11.006_bib30","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1158\/0008-5472.CAN-05-1343","article-title":"A tumorigenic subpopulation with stem cell properties in melanomas","volume":"65","author":"Fang","year":"2005","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.semcancer.2022.11.006_bib31","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jtho.2021.07.018","article-title":"Overcoming Chemotherapy Resistance in SCLC","volume":"16","author":"Herzog","year":"2021","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"11","key":"10.1016\/j.semcancer.2022.11.006_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10111801","article-title":"Tumour Microenvironment Stress Promotes the Development of Drug Resistance","volume":"10","author":"Seebacher","year":"2021","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.006_bib33","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/med.21573","article-title":"The A-B-C of small-molecule ABC transport protein modulators: From inhibition to activation-a case study of multidrug resistance-associated protein 1 (ABCC1)","volume":"39","author":"Wiese","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.semcancer.2022.11.006_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100715","article-title":"Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance","volume":"53","author":"Erin","year":"2020","journal-title":"Drug Resist. Update.: Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.semcancer.2022.11.006_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120760","article-title":"MRP1-targeted near infrared photoimmunotherapy for drug resistant small cell lung cancer","volume":"604","author":"Li","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.006_bib36","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.molcel.2016.09.031","article-title":"Mechanism and regulation of DNA-Protein crosslink repair by the DNA-dependent metalloprotease SPRTN","volume":"64","author":"Stingele","year":"2016","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.006_bib37","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1016\/S1470-2045(16)30123-1","article-title":"Novel therapeutic targets on the horizon for lung cancer","volume":"17","author":"Tan","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcancer.2022.11.006_bib38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2020.01.008","article-title":"DNA damage response and resistance of cancer stem cells","volume":"474","author":"Abad","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.006_bib39","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1038\/s41467-020-17551-4","article-title":"Symmetric neural progenitor divisions require chromatin-mediated homologous recombination DNA repair by Ino80","volume":"11","author":"Keil","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.006_bib40","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.radonc.2013.10.040","article-title":"CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells","volume":"110","author":"Desai","year":"2014","journal-title":"Radiother. Oncol.: J. Eur. Soc. Ther. Radiol. Oncol."},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.006_bib41","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jtho.2019.01.028","article-title":"Checkpoint kinase 1 inhibition enhances cisplatin cytotoxicity and overcomes cisplatin resistance in SCLC by promoting mitotic cell death","volume":"14","author":"Hsu","year":"2019","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"10.1016\/j.semcancer.2022.11.006_bib42","article-title":"Strategies for the construction of mouse models with humanized immune system and evaluation of tumor immune checkpoint inhibitor therapy","volume":"11","author":"Guo","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2022.11.006_bib43","article-title":"Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation","volume":"118","author":"Guo","year":"2019","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"issue":"7","key":"10.1016\/j.semcancer.2022.11.006_bib44","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/07357907.2015.1034869","article-title":"Differential expression of cancer stem cell markers ALDH1 and CD133 in various lung cancer subtypes","volume":"33","author":"Roudi","year":"2015","journal-title":"Cancer Investig."},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.006_bib45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.lungcan.2007.08.033","article-title":"ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors","volume":"59","author":"Patel","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.semcancer.2022.11.006_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101589","article-title":"FoxM1-dependent and fatty acid oxidation-mediated ROS modulation is a cell-intrinsic drug resistance mechanism in cancer stem-like cells","volume":"36","author":"Choi","year":"2020","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.006_bib47","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.3892\/ijo.2017.4159","article-title":"BC-02 eradicates liver cancer stem cells by upregulating the ROS-dependent DNA damage","volume":"51","author":"Dou","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.006_bib48","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cmet.2017.09.009","article-title":"MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation","volume":"26","author":"Lee","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2022.11.006_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.semcancer.2019.12.021","article-title":"The tumor organismal environment: role in tumor development and cancer immunotherapy","volume":"65","author":"Dieterich","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2022.11.006_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcancer.2019.07.017","article-title":"Acquired resistance to cancer immunotherapy: role of tumor-mediated immunosuppression","volume":"65","author":"Saleh","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.006_bib51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-019-0753-2","article-title":"Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer","volume":"12","author":"Tian","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.006_bib52","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s12885-018-4389-3","article-title":"Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells","volume":"18","author":"Morrison","year":"2018","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.006_bib53","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1158\/2159-8290.CD-20-0913","article-title":"Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity","volume":"11","author":"Mahadevan","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.006_bib54","doi-asserted-by":"crossref","first-page":"1729299","DOI":"10.1080\/2162402X.2020.1729299","article-title":"PD-L1 is overexpressed on breast cancer stem cells through notch3\/mTOR axis","volume":"9","author":"Mansour","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcancer.2022.11.006_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.02.022","article-title":"PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways","volume":"450","author":"Wei","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2022.11.006_bib56","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.2147\/OTT.S161760","article-title":"IL-8 regulates the stemness properties of cancer stem cells in the small-cell lung cancer cell line H446","volume":"11","author":"Jin","year":"2018","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.006_bib57","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/s41467-018-04313-6","article-title":"STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion","volume":"9","author":"Hsu","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.006_bib58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/08820139.2017.1280051","article-title":"Immunomodulating and immunoresistance properties of cancer-initiating cells: implications for the clinical success of immunotherapy","volume":"46","author":"Maccalli","year":"2017","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.semcancer.2022.11.006_bib59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semcancer.2018.09.006","article-title":"The role of cancer stem cells in the modulation of anti-tumor immune responses","volume":"53","author":"Maccalli","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2022.11.006_bib60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gene.2019.04.019","article-title":"LncRNA CASC11 promotes TGF-\u03b21, increases cancer cell stemness and predicts postoperative survival in small cell lung cancer","volume":"704","author":"Fu","year":"2019","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.006_bib61","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1093277","article-title":"Small cell lung cancer: recruitment of macrophages by circulating tumor cells","volume":"5","author":"Hamilton","year":"2016","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.006_bib62","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1158\/1078-0432.CCR-09-1983","article-title":"Glioma-associated cancer-initiating cells induce immunosuppression","volume":"16","author":"Wei","year":"2010","journal-title":"Clin. Cancer Res.: An Off. J.\u00a0Am. Assoc. Cancer Res."},{"key":"10.1016\/j.semcancer.2022.11.006_bib63","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.3389\/fimmu.2020.01820","article-title":"Galectin-3 in prostate cancer stem-like cells is immunosuppressive and drives early metastasis","volume":"11","author":"Caputo","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.006_bib64","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.semcancer.2022.11.006_bib65","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28862","article-title":"Role of cancer stem cell-associated inflammation in creating pro-inflammatory tumorigenic microenvironments","volume":"3","author":"Jinushi","year":"2014","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.006_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/biology10060502","article-title":"Characterization of tumor-associated macrophages and the immune microenvironment in limited-stage neuroendocrine-high and -low small cell lung cancer","volume":"10","author":"Dora","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.semcancer.2022.11.006_bib67","article-title":"Prostate cancer peripheral blood NK cells show enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 production and secrete monocyte-recruiting and polarizing factors","volume":"11","author":"Gallazzi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2022.11.006_bib68","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lungcan.2017.01.003","article-title":"The cell-cell interaction between tumor-associated macrophages and small cell lung cancer cells is involved in tumor progression via STAT3 activation","volume":"106","author":"Iriki","year":"2017","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.semcancer.2022.11.006_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109674","article-title":"Tumor-initiating stem cell shapes its microenvironment into an immunosuppressive barrier and pro-tumorigenic niche","volume":"36","author":"He","year":"2021","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.006_bib70","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190457","article-title":"Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme","volume":"217","author":"Koliaraki","year":"2020","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.006_bib71","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.1500447","article-title":"Preferentially target tumor cells with a cancer stem cell phenotype","volume":"195","author":"Ames","year":"2015","journal-title":"J. Immunology"},{"issue":"7","key":"10.1016\/j.semcancer.2022.11.006_bib72","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1158\/0008-5472.CAN-20-2808","article-title":"Evasion of innate immunity contributes to small cell lung cancer progression and metastasis","volume":"81","author":"Zhu","year":"2021","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.semcancer.2022.11.006_bib73","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/intimm\/dxp047","article-title":"Natural killer cells kill human melanoma cells with characteristics of cancer stem cells","volume":"21","author":"Pietra","year":"2009","journal-title":"Int. Immunol."},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.006_bib74","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.4049\/jimmunol.0802845","article-title":"NK cells recognize and kill human glioblastoma cells with stem cell-like properties","volume":"182","author":"Castriconi","year":"2009","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.006_bib75","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jtho.2020.05.008","article-title":"Harnessing natural killer immunity in metastatic SCLC","volume":"15","author":"Best","year":"2020","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.006_bib76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","article-title":"Dendritic cell biology and its role in tumor immunotherapy","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.semcancer.2022.11.006_bib77","article-title":"Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells","author":"Liao","year":"2022","journal-title":"Cancer Immunol., Immunother.: CII"},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.006_bib78","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.canlet.2016.01.021","article-title":"Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses","volume":"374","author":"Dashti","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2022.11.006_bib79","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/MD.0000000000004766","article-title":"Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.semcancer.2022.11.006_bib80","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.omto.2020.06.019","article-title":"CD133 mRNA-Loaded dendritic cell vaccination abrogates glioma stem cell propagation in humanized glioblastoma mouse model","volume":"18","author":"Do","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.semcancer.2022.11.006_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115699","article-title":"Targeting CD166 lung cancer stem cells: Molecular study using murine dendritic cell vaccine","volume":"429","author":"El-Ashmawy","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"16","key":"10.1016\/j.semcancer.2022.11.006_bib82","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1158\/0008-5472.CAN-15-2664","article-title":"Therapeutic efficacy of cancer stem cell vaccines in the adjuvant setting","volume":"76","author":"Hu","year":"2016","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.006_bib83","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/CJI.0000000000000242","article-title":"Cancer stem cell vaccination with PD-L1 and CTLA-4 blockades enhances the eradication of melanoma stem cells in a mouse tumor model","volume":"41","author":"Zheng","year":"2018","journal-title":"J. Immunother."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.006_bib84","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.stem.2020.06.022","article-title":"BMI1 inhibition eliminates residual cancer stem cells after PD1 blockade and activates antitumor immunity to prevent metastasis and relapse","volume":"27","author":"Jia","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.006_bib85","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.006_bib86","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/1878-0261.12741","article-title":"Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution","volume":"14","author":"Dora","year":"2020","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.006_bib87","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/imr.12132","article-title":"Exploiting the curative potential of adoptive T-cell therapy for cancer","volume":"257","author":"Hinrichs","year":"2014","journal-title":"Immunol. Rev."},{"issue":"21","key":"10.1016\/j.semcancer.2022.11.006_bib88","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMc1712460","article-title":"More on anti-CD19 CAR T cells in CNS diffuse Large-B-Cell lymphoma","volume":"377","author":"Tiberghien","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.semcancer.2022.11.006_bib89","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41573-021-00189-2","article-title":"Navigating CAR-T cells through the solid-tumour microenvironment","volume":"20","author":"Hou","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"18","key":"10.1016\/j.semcancer.2022.11.006_bib90","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.jacc.2021.08.044","article-title":"Adverse cardiovascular and pulmonary events associated with chimeric antigen receptor T-Cell therapy","volume":"78","author":"Goldman","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.006_bib91","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.stem.2020.04.008","article-title":"The rational development of CD133-Targeting immunotherapies for glioblastoma","volume":"26","author":"Vora","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.semcancer.2022.11.006_bib92","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.apsb.2020.12.015","article-title":"Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects","volume":"11","author":"Masoumi","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.semcancer.2022.11.006_bib93","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.canlet.2021.08.012","article-title":"Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer","volume":"520","author":"Taromi","year":"2021","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.semcancer.2022.11.006_bib94","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/stem.1373","article-title":"Tumorigenic potential of miR-18A* in glioma initiating cells requires NOTCH-1 signaling","volume":"31","author":"Turchi","year":"2013","journal-title":"Stem Cells"},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.006_bib95","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1158\/1078-0432.CCR-20-2845","article-title":"AMG 757, a Half-Life Extended, DLL3-Targeted bispecific T-Cell engager, shows high potency and sensitivity in preclinical models of small-cell lung cancer, Clinical cancer research: an official journal of the American Association for","volume":"27","author":"Giffin","year":"2021","journal-title":"Cli. Cancer Res.: An Off. J.\u00a0Am. Assoc. Cancer Res."},{"issue":"16","key":"10.1016\/j.semcancer.2022.11.006_bib96","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1111\/bph.13966","article-title":"Melatonin: does it have utility in the treatment of haematological neoplasms?","volume":"175","author":"Li","year":"2018","journal-title":"Br. J. Pharm."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.006_bib97","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1212\/WNL.0000000000011264","article-title":"Risk of stroke in cancer survivors: a meta-analysis of population-based cohort studies","volume":"96","author":"Zhang","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.semcancer.2022.11.006_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.684807","article-title":"The regulatory network and potential role of LINC00973-miRNA-mRNA ceRNA in the progression of non-small-cell lung cancer","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2022.11.006_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114285","article-title":"A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy","volume":"189","author":"Sun","year":"2021","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.semcancer.2022.11.006_bib100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.semcancer.2017.09.009","article-title":"FOXO1: another avenue for treating digestive malignancy?","volume":"50","author":"Shi","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2022.11.006_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2022.07.009","article-title":"Dysregulated FOXM1 signaling in the regulation of cancer stem cells","author":"Sher","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2022.11.006_bib102","article-title":"Targeting cancer stem cells by nutraceuticals for cancer therapy","author":"Chu","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2022.11.006_bib103","article-title":"Insight into the role of multiple signaling pathways in regulating cancer stem cells of gynecologic cancers","author":"Song","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2022.11.006_bib104","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.semcancer.2020.08.014","article-title":"Epigenetic regulation of cancer stem cells by the aryl hydrocarbon receptor pathway","volume":"83","author":"Akhtar","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"33","key":"10.1016\/j.semcancer.2022.11.006_bib105","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1038\/s41388-022-02391-x","article-title":"PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma","volume":"41","author":"Thirusangu","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2022.11.006_bib106","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-3-030-14366-4_3","article-title":"Heterogeneity of small cell lung cancer stem cells","volume":"1139","author":"Prabavathy","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.006_bib107","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.21037\/tlcr-20-467","article-title":"Arsenic trioxide inhibits the growth of cancer stem cells derived from small cell lung cancer by downregulating stem cell-maintenance factors and inducing apoptosis via the Hedgehog signaling blockade","volume":"9","author":"Chang","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.semcancer.2022.11.006_bib108","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pharmthera.2017.03.008","article-title":"Current modalities in cancer immunotherapy: immunomodulatory antibodies, CARs and vaccines","volume":"178","author":"Lohmueller","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.006_bib109","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/stem.2329","article-title":"Stem cells antigen-1 enriches for a cancer stem cell-like subpopulation in mouse gastric cancer","volume":"34","author":"Park","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.semcancer.2022.11.006_bib110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bcp.2018.12.010","article-title":"Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting","volume":"160","author":"Heng","year":"2019","journal-title":"Biochem. Pharmacol."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X22002280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X22002280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:03:51Z","timestamp":1760918631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X22002280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":110,"alternative-id":["S1044579X22002280"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2022.11.006","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of stem cells in small-cell lung cancer: Evidence from chemoresistance to immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2022.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}